Supremely valuable information...and CCR5 definitely inhabits the conversation,...Butt,...We've come light years ahead in the last 2 years...the conversation about Safety and Efficacy,...more trials etc... with regard to Leronlimab...is essentially historical in nature...leadership has a handle on that.

Hold lift...ESMO...added pre-clinicals...adds to the value and weight of Leronlimab. The winds are fair,...we are circling for a landing.